产品名称 GSK 690693
产品货号 Axon 1729 CAS [937174-76-0] MF C21H27N7O3MW 425.48 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Potent and ATP-competitive Akt kinase inhibitor, with IC50 to be 2, 13 and 9 nM for Akt1, Akt2 and Akt3 respectively References Certificates Categories Extra info N Rhodes et al. Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity. Cancer Res. 2008, 68(7), 2366-2374.   DA Heerding et al. Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. J. Med. Chem. 2008, 51(18), 5663-5679.   DS Lew et al. AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines. Blood. 2009, 113(8), 1723-1729. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Akt PI3K-Akt-mTOR EC 2.7.11.1 ATP-competitive pan-Akt kinase inhibitor Chemical name (S)-4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol Parent CAS No. [937174-76-0] Order Size Unit Price Stock 5 mg €115.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

GSK 690693

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1729

CAS [937174-76-0]

MF C21H27N7O3
MW 425.48

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in DMSO

GSK 690693

Description

Potent and ATP-competitive Akt kinase inhibitor, with IC50 to be 2, 13 and 9 nM for Akt1, Akt2 and Akt3 respectively
产品资料